Atomic AI is an emerging biotechnology company exploiting the cutting-edge fusion of artificial intelligence and structural biology to unlock RNA drug discovery. Based on research prominently featured in Science, Atomic AI's proprietary R&D platform leverages state-of-the-art deep learning foundation models integrated into a virtuous cycle with purpose-designed, in-house wet-lab assays, to discover and design proprietary 3D RNA structural datasets.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/25/23 | $35,000,000 | Series A |
8VC AME Cloud Ventures Doug Mohr FactoryHQ Greylock Nat Friedman Neal Khosla Not Boring Capital Patrick Hsu Playground Global  | undisclosed |
